期刊文献+

大肠癌中pAkt、VEGF和MVD的检测及其临床意义 被引量:2

Significance of and pAkt,VEGF and intratumour MVD in colorectal carcinomas
下载PDF
导出
摘要 目的检测大肠癌组织磷酸化丝氨酸/苏氨酸激酶(pAkt)、血管内皮生长因子(VEGF)的表达和微血管密度(MVD)及其临床意义。方法应用免疫组化SP法检测76例大肠癌的pAkt、VEGF和MVD。结果大肠癌pAkt和VEGF的阳性表达率分别为73.7%(56/76)和85.5%(65/76)。pAkt的阳性表达与肿瘤浸润深度、临床分期和淋巴结转移(P<0.05)及其MVD(P<0.01)显著相关。pAkt阳性组的MVD明显高于阴性组。VEGF的阳性表达与大肠癌的临床分期显著相关(P<0.05)。pAkt蛋白表达与VEGF蛋白表达密切相关(P<0.05)。结论pAkt和VEGF与大肠癌发生、发展和转移密切相关,提示阻断pI3K/Akt信号传导通路将对大肠癌的治疗提供新的靶点。 Objective To study effect of the expression of phosphorylated Akt (pAkt), vascular endothelial growth factor (VEGF) and on intratumour microvessel density (MVD)in colorectal carcinoma tissues. Methods method was used to detect the expression of pAkt, VEGF and MVD in 76 colorectal carcinomas. Results The positive expression rates of pAkt and VEGF of colorectal carcinoma were 73.7 % (56/76) and 85.5 % (65/76) respectively. The positive expression of pAkt was correlated to the invasive depth, clinical staging, lymph node metastasis and intratumor MVD. The positive expression of VEGF was closely related to clinical staging. The expression of pAkt and VEGF was positively correlation. Conclusion The results shown that pAkt and VEGF might have important significance in the carcinogenesis, progression, and metastasis of colorectal carcinoma, and pI3K/Akt might be as a potentially useful target for therapeutic intervention in colorectal carcinoma patients.
机构地区 解放军第
出处 《诊断病理学杂志》 CSCD 2009年第5期337-339,共3页 Chinese Journal of Diagnostic Pathology
  • 相关文献

参考文献18

  • 1周晓东,于皆平,于红刚,罗和生,吕农华,朱萱.蛋白激酶B在胃癌中的表达及其生物学意义[J].中华消化杂志,2005,25(7):401-405. 被引量:21
  • 2Yamamoto K, Tomita Y, Hoshida J, et al. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma [ J ]. Clin Cancer Res, 2004, 10(8): 2846-2850.
  • 3Grabacka M, Plonka PM, Urbanska K, et al. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt [J]. Clin Cancer Res, 2006, 12(10) :3028 - 3036.
  • 4Oka N, Tanimoto S, TAUE R, et al. Role of phosphatidylinositol 3- kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand[J]. Cancer, 2006, 97(10): 1093- 1098.
  • 5Shinohara M, Chung YJ, Saji M, et al. AKT in thyroid tumorigenesis and progression [ J]. Endocrinology, 2007, 148 ( 3 ) : 942 - 947.
  • 6ZHENGShu CAIShanrong.Colorectal Cancer Epidemiology and Prevention Study in China(中国人大肠癌的流行病学研究)[J].The Chinese-German Journal of Clinical Oncology,2003,2(2):72-75. 被引量:45
  • 7Macchiarini P, Fontanini G, Hardin MJ, et al. Relation of neovascularisation to metastasis of non small cell lung cancer [J]. Lancer, 1992,340(881) : 145 - 146.
  • 8Lee WJ, Chen WK, Wang CJ, et al. Apigenin inhibits HGF- promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells [J]. Toxicol Appl Pharmacol, 2008, 226(2) : 178 - 191.
  • 9Lin HL, Chiou SH, Wu CW, et al. Combretastatin A4-induced differential cytotoxicity and reduced metastatic ability by inhibition of Akt function in human gastric cancer cells [J]. J Pharmacol Exp Ther, 2007,323(1) :365 - 373.
  • 10Bedogni B, Neill MS, Welony SM, et al. Topical treatment with inhibitors of the phosphatidylinositol 3-kinase/Akt and Raf/mtogenactivted protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodeficient mice[J]. Cancer Res 2004, 64(7) : 2552 - 2560.

二级参考文献25

  • 1刘希永,周伦,余海,郑树,陈坤,焦登鳌,袁亚昌,马新源.嘉善县286例大肠癌病例-对照研究[J].中国慢性病预防与控制,1994,2(3):122-123. 被引量:13
  • 2杨工,高玉堂,胡应,季步天,郑树,高汝聂.大肠癌的遗传流行病学研究──Ⅰ.分离比与遗传率估计[J].中华医学遗传学杂志,1994,11(1):9-11. 被引量:6
  • 3周伦,余海,郑树.结直肠癌优化筛检方案在大肠癌高发区人群中的验证[J].中国慢性病预防与控制,1997,5(2):75-76. 被引量:4
  • 4Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science,1997,275:661-665.
  • 5Burgering BM, Coffer PJ. Protein kinase B(c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature,1995,376: 599-602.
  • 6Schlieman MG, Fahy BN, Ramsamooj R, et al. Incidence,mechanism and prognostic value of activated AKT in pancreas cancer. Br J Cancer, 2003,89:2110-2115.
  • 7Ringel MD, Hayre N, Saito J, et al. Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res, 2001, 61:6105-6111.
  • 8Itoh N, Semba S, Ito M, et al. Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer, 2002,94:3127-3134.
  • 9Liu AX, Testa JR, Hamilton TC, et al. AKT2, a member of the protein kinase B family, is activated by growth factors,v-Ha-fas, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res, 1998, 58:2973-2977.
  • 10Sambrook J, Fritsch EF, Maniatis T, eds Molecular cloning: A laboratory manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989.

共引文献64

同被引文献9

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部